Azithromycin vs Roflumilast for AECOPD
A UCLA Health study compared azithromycin and roflumilast in protecting against acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Tag: COPD
All
Latest
Azithromycin vs Roflumilast for AECOPD
A UCLA Health study compared azithromycin and roflumilast in protecting against acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Read More
COPD Foundation to Host Patient-Focused Drug Development Meeting
The COPD Foundation announced an upcoming meeting to ensure patient experiences and priorities are incorporated into the future of therapeutic development.
Read More
Rapid Test for COPD Exacerbations Begins Study
ProAxsis and Imperial College London are investigating the NEATstik test, which detects active neutrophil elastase (NE) in sputum samples.
Read More
Testosterone Treatment Linked to Reduced Inhaled Steroid Use
Men receiving systemic testosterone therapy showed a statistically significant decrease in inhaled corticosteroid use starting 18 to 24 months after treatment initiation.
Read More
bioAffinity, Pictor Collaborate on Asthma and COPD Tests
The collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
Read More
Daily Walks Near Traffic Pollution Increased COPD Cough, Sputum
Traffic-related air pollution can worsen respiratory symptoms during daily exercise for people with chronic lung disease.
Read More
Twice-yearly COPD Biologic Begins Trial
Windward Bio is evaluating WIN378, a monoclonal antibody designed for twice-yearly dosing in patients with moderate-to-severe COPD.
Read More
Voice Changes May Help Monitor Asthma and COPD at Home
New research suggests acoustic speech features can identify respiratory exacerbations from the first day of onset.
Read More
Lung Denervation Trial to Target COPD Phenotype
Nuvaira treated the first patient treated in a clinical trial evaluating a one-time lung denervation therapy for patients with specific COPD symptoms.
Read More
American Lung Association Launches COPD Management Program
American Lung Association is launching a new initiative to help the more than 16 million people in the US living with COPD manage symptoms and improve quality of life.
Read More
Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial
Grifols enrolled the first patient in its Phase 3 SWIFT-SC clinical trial to evaluate its subcutaneous Alpha1-Proteinase Inhibitor for the treatment of alpha1-antitrypsin (AAT) deficiency.
Read More
COPD Patients Need More Education on Wildfire Smoke Risks
New research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.
Read More
ENA Respiratory Secures Two US Patents for COPD Therapy
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
Read More
Inhaled Vitamin D for COPD, Asthma
Researchers suggest delivering vitamin D directly to the lungs could bypass the limitations of oral supplements in treating COPD and asthma.
Read More
Nebulized Dual Bronchodilator Aero-007 Improved COPD Lung Function
AERO-007 demonstrated significant lung function improvements over 24 hours in patients with moderate-to-severe COPD.
Read More
Worse COPD, Pneumonia Outcomes at Private Equity Hospitals
Patients with pneumonia or COPD faced higher mortality risks and readmission at facilities owned by private equity firms, according to new research.
Read More
Alpha-1 Drug Candidate Superior to Standard Care
Phase 2 data for efdoralprin alfa demonstrate the recombinant protein maintains normal protein levels with less frequent dosing than current standards of care for patients with alpha-1 antitrypsin deficiency (AATD)-related emphysema.
Read More
Viz.ai Launches Ai-powered Viz Pulmonary Suite
The new suite integrates workflows for COPD, lung nodules, and pulmonary embolism to improve patient follow-up and treatment times.
Read More
Why Some Alpha-1 Patients Develop Liver Disease
A newly discovered biological process protects liver cells from protein buildup in patients with alpha-1-antitrypsin deficiency.
Read More
ALA Launches Study to Test Omalizumab for COPD Flare-ups
The COPD-OMA trial will examine if the asthma drug omalizumab (Xolair) benefits COPD patients with sensitivities to indoor allergens.
Read More
WHO Expands Asthma Care in Nepal, Sri Lanka
The initiative focuses on integrating respiratory services into primary healthcare to improve diagnosis and treatment access.
Read More
Tozorakimab Reduces COPD Flare-Ups in Ph3 Trial
The MIRANDA study found tozorakimab significantly lowered the rate of moderate-to-severe respiratory worsening in patients regardless of smoking history or specific white blood cell counts.
Read More
Soy, Legumes May Improve COPD Symptoms
New research suggests isoflavones found in plant-based foods like soy and legumes can reduce inflammation and coughing for patients with COPD.
Read More
Phone-based Training Improves COPD Inhaler Use
A study of Medicare Advantage beneficiaries with COPD shows that pharmacist-led telephone education significantly reduces errors in medication delivery.
Read More